Biotech penny stocks are rockin’ again this week.
Plus we have plenty of catalysts to drive the action — drug news, Reddit hype, and institutional investment in one of these companies…
And some tickers return to the watchlist from last week. I’m watching for some to continue their upward momentum. It may seem like the party’s over for others, but I’m watching those for potential dip buys into big panics.
Whether you like breakouts, dip buys, or gambling on Reddit hype (please don’t), there’s something for nearly everyone on this week’s watchlist.
But don’t just jump into any stock moving. Create a process for building your watchlists and trading plans. Then stay disciplined and ALWAYS cut losses quickly. Now, get to work!
Here are the top biotech penny stocks I’m watching this week and why.
10:42pm study check, retweet/favorite this if you’re up studying, making your watchlist or if you made a trade or papertrade on @StocksToTrade today! Every day you should remember to learn a little something new, not necessarily trade…growing your knowledge account is PRIORITY!
— Timothy Sykes (@timothysykes) June 15, 2021
Top Biotech Penny Stocks to Watch
These are the top stocks on my watchlist. ‘Watch’ is the key word here. There’s no guarantee that there’ll be a trading opportunity. Remember, these stocks move FAST.
Before we get to my list of stocks to watch, here are a few of my top resources for penny stocks…
- If you’re new to penny stocks, start here with this FREE online guide.
- Ready to learn how to build your own stock watchlist? This post is for you.
- Discover how I find all the stocks on my watchlists here.
How do I find hot stocks? I use StocksToTrade every day. For me, it’s the best tool because I helped design it specifically for trading penny stocks. (I’m also an investor.) It has awesome charts, built-in scans, social media feeds, and so much more to help you do your research.
And its Breaking News Chat add-on feature is a game-changer in this hot market. It helped me make record profits in 2020.* Get a StockToTrade 14-day trial for only $7…
Or try it with the Breaking News Chat for only $17!
Now, let’s get to the top biotech penny stocks to watch this week…
Biotech Penny Stocks #1: PharmaTher Holdings Ltd. (OTCQB: PHRRF)
PHRRF is a biotech company focused on developing psychedelic treatments for schizophrenia, autism, depression, and other nervous system disorders.
The stock returns to the watchlist from last week. It continues to uptrend and volume’s increasing.
Yesterday the company announced it filed a pre-investigational new drug application with the FDA for its potential depression treatment.
Read the full press release here.
I’ll watch it for a breakout over 8 cents.
Biotech Penny Stocks #2: Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)
RIGL develops drugs for the potential treatment of rare diseases, disorders, and cancer.
On June 14, the company was featured in a Seeking Alpha article that touted the company’s potential COVID-19 treatment.
The stock had a green day after the article’s release. The following day it consolidated. I’m watching for a multi-day breakout over $4.43.
Biotech Penny Stocks #3: Zosano Pharma Corporation (NASDAQ: ZSAN)
ZSAN works to develop therapies for migraines. In May it announced that study results from its potential migraine treatment were published in The Journal of Headache and Pain…
“Participants achieved pain relief at two hours post-dose in 81% of migraine attacks, pain freedom in 44% of attacks, and most bothersome symptom freedom in 62% of attacks.
“The majority of participants experienced cutaneous application site reactions where the Qtrypta patch was applied, of which more than 95% were rated as mild. More than 80% of swelling and redness incidents were resolved (rated as zero) by 48 hours following application.”
Read the full press release here.
The stock’s trading higher volume since the news came out. And it’s a former runner, so it could run again. It’s another one I’m watching for a multi-day breakout over $1.07.
Biotech Penny Stocks #4: Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)
CTXR is a biotech that develops critical care products. Its antibiotic lock solution is in phase 3 clinical trials.
In a June 8 press release, the company announced it will release more data at the end of June.
On June 15, it announced new members joined its Scientific Advisory Board.
The stock’s also trending on Reddit and was on my Reddit penny stock watchlist this week.
After the June 15 news, it had a big breakout over $3. I’ll watch for it to potentially continue higher on the Reddit chat room hype, but I won’t chase. I’ll watch for dip-buy opportunities.
Biotech Penny Stocks #5: Sesen Bio, Inc. (NASDAQ: SESN)
SESN develops potential cancer treatments. It’s another stock returning from last week’s watchlist as it continues to make new 52-week highs.
On June 8, the company filed a Form 8-K stating, “the Company is expected to be included in the Russell 3000® Index effective after the US market opens on June 28, 2021, according to a preliminary list of additions.”
The stock has been in a strong uptrend but may be getting overextended. I’ll watch this one for a morning panic dip-buy opportunity.
Biotech Penny Stocks #6: VBI Vaccines Inc. (NASDAQ: VBIV)
VBIV develops cancer, coronavirus, and infectious disease vaccines.
It’s another stock returning to the watchlist, and it’s also getting some attention in Reddit penny stock chat rooms. Reddit traders like the June 8 news that the FDA granted Fast Track designation for the company’s cancer vaccine.
The stock’s consolidating around $4. I’ll watch it for a breakout over $4.30. But if it breaks down below $3.80, I’ll watch for a morning panic dip-buy opportunity.
Biotech Penny Stocks #7: Agenus Inc. (NASDAQ: AGEN)
AGEN is an immuno-oncology company.
It’s also returning from last week’s watchlist. Right now it’s trading around the penny stock border of $5.
It had a good run-up last week, but the volume’s fading. It looks like it’s losing momentum. I’ll watch it for a morning panic dip-buy opportunity.
Biotech Penny Stocks #8: Clearside Biomedical, Inc. (NASDAQ: CLSD)
CLSD develops potential treatments for serious eye diseases.
On June 15 it announced positive safety results from its Phase 1/2 clinical trial of its potential treatment for age-related macular degeneration (wet AMD).
“The primary endpoints were achieved in Cohort 1, as the initial lowest planned dose of 0.03 mg CLS-AX was well tolerated with no serious adverse events and no drug related treatment emergent adverse events observed throughout the study period.”
Read the full press release here.
After the news, the stock gapped up from roughly $3 to almost $6 in premarket trading. It opened at $4 and made a daily high of $4.80. Then traded sideways for most of the day. I’ll watch it for more potential upside and a possible short squeeze.
Biotech Penny Stocks #9: Organicell Regenerative Medicine, Inc. (OTCPK: BPSR)
BPSR focuses on developing potential treatments for patients with degenerative diseases.
On June 15 the company announced positive results from the expanded access trials of its potential treatment for COVID-19.
“Organicell will immediately submit this data to the FDA for a requested amendment to their approved IND (NCT04384445) to perform a placebo-controlled Phase 2 clinical trial to confirm safety and efficacy in a randomized fashion.”
Read the full press release here.
The stock gapped up and spiked but couldn’t hold its gains. There could be a lot of bag holders from its huge run-up in April. I’ll watch for a panic dip-buy opportunity.
Biotech Penny Stocks #10: Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX)
ELOX develops drug candidates for the potential treatment of rare and ultra-rare diseases. Its lead drug candidate is in Phase 2 trials for the potential treatment of cystic fibrosis mutations.
There’s no recent news on the company, but on June 14 the company filed a Schedule 13G showing an institutional investor now owns more than 5% of the company’s shares.
On June 15 the stock gapped up and had a multi-day breakout over $2.25, but it couldn’t hold its gains. I’ll watch for a dip-buy opportunity into a big panic.
Get the List of Penny Stocks I’m Watching Delivered to Your Inbox
Want to know which stocks I’m watching each week? Subscribe to my no-cost watchlist. I’ll send my top penny stocks to watch right to your inbox every week. It can help you learn the process I follow for every stock.
I’ll say it again … The stocks on my watchlist aren’t an automatic buy. Remember to do your own due diligence and research. If you’re trading without a trading plan, you’re gambling. Don’t be a degenerate gambler — trade smart!
👉🏼 SUBSCRIBE to my no-cost weekly stock watchlist here.
Conclusion
Biotech penny stocks are stocks of small, developmental companies. These companies are usually desperate for cash. They need it to continue developing products and for testing and trials. Trade them with caution…
They’re known to be extremely volatile. They can have huge price swings. One minute they’re flying high on positive news — the next they’re down due to bad trial results, side effects, or stock dilution.
If you’re prepared to take advantage of the price swings, these stocks can offer great trading opportunities…
In my Trading Challenge chat room, my students and I talk about the hottest penny stocks. And many top traders who got their start in the Challenge are now chat moderators who answer questions and help out new students.
If you want to join a community of top traders, apply for my Trading Challenge. I don’t accept everyone. I only want the most dedicated students who are willing to put in the time and effort it takes to become my next top student. Could it be you?
What do you think of these biotech penny stocks to watch? Let me know in the comments … I love to hear from you!
Disclaimers
*Please note that these kinds of trading results are not typical and do not reflect the experience of the majority of individuals using our products. From January 1, 2020, to December 31, 2020, typical users of the products and services offered by this website reported earning, on average, an estimated $49.91 in profit. This figure is taken from tracking user accounts on Profit.ly, a trading community platform. It takes years of dedication, hard work, and discipline to learn how to trade. Individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.
**Tim Sykes has a minority ownership stake in StockstoTrade.com.
The post Top Biotech Penny Stocks to Watch — June 16, 2021 appeared first on Timothy Sykes.